College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Department of Pharmaceutical Sciences, North South University, Dhaka, 1229, Bangladesh.
Semin Cancer Biol. 2021 Feb;69:52-68. doi: 10.1016/j.semcancer.2020.01.011. Epub 2020 Jan 31.
Nanotechnology is reshaping health care strategies and is expected to exert a tremendous impact in the coming years offering better healthcare facilities. It has led to not only therapeutic drug delivery feasibility but also to diagnostics. Materials in the size of nano range (1-100 nm) used in the design, fabrication, regulation, and application of therapeutic drugs or devices are classified as medical nanotechnology and nanopharmacology. Delivery of more complex molecules to the specific site of action as well as gene therapy has pushed forward the nanoparticle-based drug delivery to its maximum. Areas that benefit from nano-based drug delivery systems are cancer, diabetes, infectious diseases, neurodegenerative diseases, blood disorders and orthopedic-related ailments. Moreover, development of nanotherapeutics with multi-functionalities has a considerable potential to fill the gaps that exist in the present therapeutic domain. In cancer treatment, nanomedicines have superiority over current therapeutic practices as they can effectively deliver the drug to the affected tissues, thus reducing drug toxicities. Along this line, polymeric conjugates of asparaginase and polymeric micelles of paclitaxel have recently been recommended for the treatment of various types of cancers. Nanotechnology-based therapeutics and diagnostics provide greater effectiveness with less or no toxicity concerns. Similarly, diagnostic imaging holds promising future applications with newer nano-level imaging elements. Advancements in nanotechnology have emerged to a newer direction which use nanorobotics for various applications in healthcare. Accordingly, this review comprehensively highlights the potentialities of various nanocarriers and nanomedicines for multifaceted applications in diagnostics and drug delivery, especially the potentialities of polymeric nanoparticle, nanoemulsion, solid-lipid nanoparticle, nanostructured lipid carrier, self-micellizing anticancer lipids, dendrimer, nanocapsule and nanosponge-based therapeutic approaches in the field of cancer. Furthermore, this article summarizes the most recent literature pertaining to the use of nano-technology in the field of medicine, particularly in treating cancer patients.
纳米技术正在重塑医疗保健策略,并有望在未来几年产生巨大影响,提供更好的医疗保健设施。它不仅带来了治疗性药物输送的可行性,也带来了诊断学的进步。用于设计、制造、调节和应用治疗性药物或设备的纳米范围内(1-100nm)的材料被归类为医学纳米技术和纳米药理学。将更复杂的分子递送到特定的作用部位以及基因治疗,推动了基于纳米颗粒的药物输送达到了极限。受益于基于纳米的药物输送系统的领域包括癌症、糖尿病、传染病、神经退行性疾病、血液疾病和骨科相关疾病。此外,具有多功能的纳米治疗药物的开发具有相当大的潜力,可以填补当前治疗领域存在的空白。在癌症治疗中,纳米药物优于当前的治疗方法,因为它们可以将药物有效地递送到受影响的组织,从而降低药物的毒性。沿着这条线,天冬酰胺酶的聚合物缀合物和紫杉醇的聚合物胶束最近被推荐用于治疗各种类型的癌症。基于纳米技术的治疗学和诊断学提供了更高的疗效,同时减少或没有毒性问题。同样,诊断成像具有有前途的未来应用,具有更新的纳米级成像元素。纳米技术的进步已经出现了一个新的方向,即使用纳米机器人在医疗保健的各个领域中进行各种应用。因此,本综述全面强调了各种纳米载体和纳米药物在诊断和药物输送方面的多方面应用的潜力,特别是聚合物纳米颗粒、纳米乳液、固体脂质纳米颗粒、纳米结构脂质载体、自乳化抗癌脂质、树枝状大分子、纳米胶囊和纳米海绵基于治疗方法在癌症领域的潜力。此外,本文总结了与纳米技术在医学领域,特别是在治疗癌症患者中的应用相关的最新文献。
Biomed Pharmacother. 2017-11-21
Eur J Pharm Biopharm. 2015-6
Curr Drug Deliv. 2016
Semin Cancer Biol. 2021-2
Semin Cancer Biol. 2021-2
Nanomedicine. 2015-11
Mater Today Bio. 2025-8-3
Int J Nanomedicine. 2025-5-31